MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Pharmaceutical Executive
August 1, 2013
Jacobs & Calkins
Prescription for Growth: Embrace a Niche The best way to grow in the pharma industry is to think small. mark for My Articles similar articles
Pharmaceutical Executive
July 30, 2007
Stewart Young
Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds. mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2005
Richard B. Vanderveer
Position, Position, Position The "weekender," the "doughnut hole," and the secret art of "bathroom mapping": How pharma marketers are learning to tell new stories for every phase of a drug's lifecycle. mark for My Articles similar articles
CRM
February 2012
Leonard Klie
CRM Is a High-Yield Investment Business analytics return $10.66 for every dollar spent; CRM systems return $5.60. mark for My Articles similar articles
Pharmaceutical Executive
January 21, 2014
Tim Powell
Innovation: The Moneyball Test Successful innovation now has to align with key metrics of value; can an old baseball metaphor help guide the way? mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2005
Diane West
Media Spend Trends: Changing Lanes You've got their attention---now what? Pharma marketing analysts predict a spending shift from branded direct-to-consumer efforts to more disease awareness and corporate reputation promotions. mark for My Articles similar articles
CRM
August 4, 2015
Oren Smilansky
Brainshark Adds Analytics to the Sales Accelerator Improved analytics give reps a fuller picture of rep performance throughout the sales cycle. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2005
Nickum & Kelly
Missing the Mark(et) Pharmaceutical companies spend billions on data. Sales reps crowd the waiting rooms. So why is the doctor out? mark for My Articles similar articles
The Motley Fool
November 3, 2006
Dan Caplinger
Know Your Numbers: Productivity Productivity figures released by the BLS provide a rare look at the quality of economic activity within the economy. Keeping track of changes in productivity levels can give you an indication of the sustainability of economic growth that other types of economic data can't duplicate. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2009
Brittany Agro
The New Sales Force The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with, and how it's working. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2009
Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2012
William Looney
Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2007
Bill Trombetta
Stealth Pharmas Big Pharma is different from the thousands of biotechs, specialty pharmas, generics makers, and other companies that make up Stealth Pharma. Yes, they have more money. But in what other ways are they different? And can we learn anything from the way Stealth Pharma competes? mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2011
Al Topin
Blame the Driver, Not the Car Why is building a successful pharma marketing program so difficult? It should be simple, if your product is worth marketing. mark for My Articles similar articles
Bio-IT World
June 2006
Michael A. Greeley
Backwards Influence Biotech companies must think downstream as they consider what drugs to develop. Many companies are introducing cost-effectiveness analysis earlier in the discovery process. mark for My Articles similar articles
Chemistry World
December 8, 2011
Sarah Houlton
Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2011
William Looney
R&D Costs: It's Industry's Problem If high prices that lower access are attributable to a flawed R&D model, can the pharmaceutical industry embrace delivering better results at lower costs. mark for My Articles similar articles
BusinessWeek
November 29, 2004
Catherine Arnst
Big Pharma's Blinders Hugely profitable thanks to a few blockbusters, Big Pharma is far too focused on looking for the next best-seller, causing companies to pass up opportunities to deliver important breakthroughs. mark for My Articles similar articles
IndustryWeek
February 1, 2007
David Blanchard
How To Get Your Forecasts Wrong, In Ten Easy Lessons Learn what to do - and what not to do - from this list of "forecasting fallacies." mark for My Articles similar articles
HBS Working Knowledge
July 14, 2003
Can We Have Too Much Productivity Improvement? Readers Respond mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Jeffrey Zornitsky
Sales Management: Get Committed By better managing relationships with physicians, pharma companies can develop a base of dedicated prescribers. mark for My Articles similar articles
The Motley Fool
September 9, 2004
Charly Travers
The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2014
Anbil et al.
Managed Markets: Positioning Your Product For Success with Pull Through Strategies A patient-centric approach to drug development delivers the benefits that actually create value mark for My Articles similar articles
Chemistry World
March 25, 2015
Dennis Lendrem
Be careful what you wish for There is a big debate right now in the pharmaceutical industry, and specifically about measuring R&D productivity. It all comes down to a choice of metrics. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2014
Stan Bernard
Product Positioning 2.0 Industry and market transformations have dramatically altered when and how products should be positioned for launch mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2012
Amy Smith
Marketing: Medical Devices vs. Pharma Understanding the differences between drug and device marketing can make or break the brand's promotional activities. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2005
Boschwitz et al.
Track Patients, Not Prescriptions Why pharma companies reject anonymous patient-level data, and why they can't do without it for long. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2011
Turning the Ins and Outs of Marketing Inside-Out Keeping your finger on the pulse of consumers leads to better, more actionable insights and better results. mark for My Articles similar articles
HBS Working Knowledge
March 13, 2006
Use a Rolling Forecast to Spot Trends An excerpt from Jeremy Hope's new book, Reinventing the CFO, on the concept of the rolling forecast as a flexible and meaningful supplement or alternative to traditional business measures. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2007
Thoughtleader: Thomas Nagle, Strategic Pricing Group This industry consultant believes the U.S. government will soon follow Europe's lead in taking a greater hand in price negotiations, and pharma will need to be able to communicate the value that products offer. Here he discusses how pharma can meet that challenge. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2012
Gregg DiPietro
Reforming Pharma Marketing With respect to targeting, positioning, and launching new drugs, the ACA reform stands for Adjust, Change, and Adapt. mark for My Articles similar articles
CRM
January 1, 2006
Agarwal & Schumacher
Put More Feet on the Street To extract more value from existing sales machinery, B2B companies must address fundamental sales productivity inhibitors, focusing first on process, policy, and guideline improvements. mark for My Articles similar articles
Pharmaceutical Executive
July 3, 2007
Harbingers of Change What to watch, and watch out for, in the bottom half of '07. The IMS Health Editorial Board identifies what it believes are the key events that will impact the global pharmaceutical market in the near future. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2012
Best Practices: Commercial Analytics If the relationship between marketers and commercial analytics in the pharmaceutical and biotech sectors is leveraged properly, it can help marketers make more informed strategic decisions for their brands. mark for My Articles similar articles
CIO
July 15, 2003
Ben Worthen
Future Results Not Guaranteed Contrary to what vendors tell you, computer systems alone are incapable of producing accurate forecasts. mark for My Articles similar articles
The Motley Fool
July 21, 2004
Brian Gorman
Novartis Shows the Way It may be a model for other pharmaceutical outfits looking to improve productivity. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2008
Getting Personal(ized) Stop worrying about shrinking the market for your drug, and start figuring out how the "test and treat" business model works. mark for My Articles similar articles
Bio-IT World
December 10, 2002
Jim Hall
21st Century R&D Strategy: Atlantic or Pacific? The biopharmaceutical sector is divided by two strategic perspectives. mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2008
Harbingers of Change The pharmaceutical industry is changing. Here are eight seminal events that describe how. mark for My Articles similar articles
The Motley Fool
September 15, 2011
Frank Vinluan
GSK's New Drug Marketing Model: Pharma Reps As Educators, Not Sellers The conversation between sales reps and doctors today is vastly different compared to one year ago. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Walter Armstrong
Forecast 2007: At Sea In times of crisis, it's harder than ever to take the long view. The healing arts may be as old as humankind, but the business of pharma is still in its infancy. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Glass & Poli
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2008
Patrick Clinton
Reason to Believe Here are a few things to be optimistic about in the pharmaceutical industry. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2012
Wilcox et al.
Sales Force Survey: Still Too Much Business as Usual? In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success. mark for My Articles similar articles
HBS Working Knowledge
June 27, 2005
Barber & Strack
People Power: How to Measure It Start with the right set of performance indicators. mark for My Articles similar articles
The Motley Fool
April 21, 2004
Ben McClure
Discount Pharmacy With prices beaten down across the pharmaceuticals industry and the quarterly reporting season here, do any investment opportunities pop up? mark for My Articles similar articles
Pharmaceutical Executive
August 1, 2011
Bill Drummy
The Slow Dance Toward Obsolescence Does Big Pharma have the emotional connection and intellectual commitment to move with the pace of change? mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2005
Christopher Lisanti
Physician Frustration Doctors have had enough. But reps can still redeem themselves. As the industry thinks about new sales force models, it should look beyond ROI numbers, toward a new paradigm that not only works for pharma, but also for its customers. mark for My Articles similar articles
CRM
January 2007
Colin Beasty
Forecasting a Flap Econometrics has long been the province of Ph.D.s, but applications for marketers are emerging via automated user interfaces and BI reporting tools. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2014
Longacre et al.
Social Media: Have We Reached The Tipping Point? For pharma marketers, the good news is recent advances in social media monitoring make it possible to listen to or engage with patients on social media websites. This month FDA released its draft guidance on the use of "Interactive Promotional Media." mark for My Articles similar articles